首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Comparative study of cephradine and amoxicillin-clavulanate in the treatment of recurrent urinary tract infections.
【2h】

Comparative study of cephradine and amoxicillin-clavulanate in the treatment of recurrent urinary tract infections.

机译:头孢拉定与阿莫西林-克拉维酸治疗复发性尿路感染的比较研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Eighty-eight female patients with a history of recurrent urinary tract infections were treated according to a randomization scheme with either 1 g of cephradine every 12 h (47 patients) or 375 mg of amoxicillin-clavulanate every 8 h (41 patients) for 7 days. The treatments were equally effective (cure rates of 89% for cephradine and 88% for amoxicillin-clavulanate) and showed similar relapse rates (cephradine, 14%; amoxicillin-clavulanate, 11%). Adverse effects were similar in both groups (cephradine, 23%; amoxicillin-clavulanate, 22%).
机译:根据随机方案,对有复发性尿路感染史的88名女性患者进行治疗,每12小时服用1 g头孢拉定(47位患者)或每8小时服用375 mg阿莫西林-克拉维酸盐(41位患者),持续7天。这些治疗同样有效(头孢拉定的治愈率为89%,阿莫西林-克拉维酸的治愈率为88%),并显示出相似的复发率(西法拉定为14%;阿莫西林-克拉维酸为11%)。两组的不良反应相似(头孢拉定23%;阿莫西林克拉维酸盐22%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号